Browse the latest amgen inc news online for free

United States Glucagon-like Peptide 1 (GLP-1) Analogues Market Expansion Till 2033: Eli Lilly's Mounjaro Becomes Top-Selling Weight-Loss Treatment | Most Leading Companies are Eli Lilly and Company, Novo Nordisk A/S, Hanmi Pharm. Co.., Ltd, Amgen Inc., Gm

Glucagon-like Peptide 1 (GLP-1) Analogues Market reached US$ 62.81 Billion in 2024 and is expected to reach US$ 299.08 Billion by 2033, growing at a CAGR of 17.6 % during the forecast period 2025-2033.DataM Intelligence has released its latest report Read more